对治疗应用的寡核酸-蛋白质结合的化学洞察
Shalini Gupta1, Abhishek Gupta1, Maria Mukherjee1
1School of Applied and Interdisciplinary Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.
Journal of medicinal chemistry
|May 7, 2025
概括
优化血蛋白结合是寡核酸药物成功的关键,影响组织分布并防止脏分泌. 化学修改可以平衡药物特性,并最大限度地减少副作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 药用化学 医学化学
背景情况:
- 血蛋白结合显著影响了寡核酸治疗药物的临床疗效.
- 有效的蛋白质结合对于适当的组织分布和保留至关重要,防止清除.
- 氧核酸药物特性可以通过化学修改进行微调,以增强药理动力学特征并减少非目标效应.
研究的目的:
- 为了解不同类型的寡核酸蛋白的多种血蛋白相互作用提供见解.
- 探索调节这些蛋白质结合特性的化学策略.
- 讨论量化血蛋白结合的方法,并将化学与治疗结果相关联.
主要方法:
- 关于寡核酸与血蛋白相互作用的文献综述和视角综合.
- 对调节结合的化学修饰策略的分析.
- 讨论量化技术和相关性研究.
主要成果:
- 寡核酸的宏分子结构导致动态的蛋白质结合,与小分子不同.
- 化学修饰提供了一个可行的途径,以优化结合性和药物动力学特征.
- 已建立的方法存在量化结合,与治疗成功的相关性.
结论:
- 血蛋白结合的战略调节对于成功的寡核酸药物开发至关重要.
- 了解这些相互作用有助于设计具有更高效率和安全性的药物.
- 对化学药物结果相关性的进一步研究将促进寡核酸治疗.
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Protein-Drug Binding: Determination Methods
106
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
106
The Equilibrium Binding Constant and Binding Strength
12.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.7K
Protein-Drug Binding: Mechanism and Kinetics
233
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
233
Factors Affecting Protein-Drug Binding: Drug-Related Factors
68
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
68


